Ismael Compañón

1.2k citations
38 papers · 961 indexed · h-index 18

Ismael Compañón

36 papers receiving 957 citations

Peers

Ismael Compañón
Comparison fields: 5 of 74
  • Molecular Biology 778
  • Organic Chemistry 560
  • Radiology, Nuclear Medicine and Imaging 204
  • Immunology 156
  • Oncology 123
Replace Yoshiyuki Manabe with:
Yoshiyuki Manabe Japan
Mahmud M. Hussain United States
Brian P. Smart United States
Peter W. Glunz United States
Barbara Beck Germany
Barbro Beijer Germany
Fayna García‐Martin Japan
Nuria Martínez‐Sáez Spain
Hiroko Togame Japan
Ismael Compañón relative to Yoshiyuki Manabe Japan Yoshiyuki Manabe's profile →
Citations per field
00.5×2.8×
Yoshiyuki Manabe · 1×
Citations per year

Countries citing papers authored by Ismael Compañón

Since Specialization
Citations

This map shows the geographic impact of Ismael Compañón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ismael Compañón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ismael Compañón more than expected).

Fields of papers citing papers by Ismael Compañón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ismael Compañón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ismael Compañón. The network helps show where Ismael Compañón may publish in the future.

Co-authorship network of co-authors of Ismael Compañón

This figure shows the co-authorship network connecting the top 25 collaborators of Ismael Compañón. A scholar is included among the top collaborators of Ismael Compañón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ismael Compañón. Ismael Compañón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 7
4 2
5 0
6 4
7 17
8 31
9 5
10 39
11 12
12 59
13 12
14 15
15 41
16 42
17 8
18 65
19 75
20 78

About Ismael Compañón

Ismael Compañón is a scholar working on Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 38 papers that have together received 961 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (23 papers), Carbohydrate Chemistry and Synthesis (19 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). The work is most often cited by research in Organic Chemistry (560 citations), Molecular Biology (778 citations) and Radiology, Nuclear Medicine and Imaging (204 citations). Ismael Compañón has collaborated with scholars based in Spain, Portugal and United Kingdom. Frequent co-authors include Francisco Corzana, Ramón Hurtado‐Guerrero, Jesús M. Peregrina, Gonçalo J. L. Bernardes, Henrik Clausen, Jesús Jiménez‐Barbero, Gonzalo Jiménez‐Osés, Alberto Avenoza, Jesús H. Busto and Erandi Lira‐Navarrete. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026